Manufacturing facility
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.800, Haifa Road, Chengdu Cross-strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu, Sichuan 611130, China (CHN)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3019967180 · DUNS 404080894
Drugs this plant is listed as making
2 distinct drugs across 12 products name this site in their FDA label.
- Albuterol SulfateLuoxin Aurovitas Pharma (Chengdu) Co., Ltd.
- LevalbuterolLuoxin Aurovitas Pharma (Chengdu) Co., Ltd.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.